- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:34 | Amgen Q2 Earnings Preview: Will the Beat Streak Continue? | 5 | Zacks | ||
| 18:32 | Scancell Holdings - Holding(s) in Company | - | RNS | ||
| 18:22 | Stifel erhöht Kursziel für Neurocrine Bio nach starken Ergebnissen | 1 | Investing.com Deutsch | ||
| 18:22 | PureTech Health gibt Aktien an Non-Executive Directors aus | 2 | Investing.com Deutsch | ||
| 18:18 | Stifel raises Neurocrine Bio stock price target on strong earnings | 1 | Investing.com | ||
| 18:18 | Stifel raises Illumina stock price target to $225 on strong demand | 3 | Investing.com | ||
| 18:18 | PureTech Health issues shares to non-executive directors | 2 | Investing.com | ||
| 18:12 | Moderna reiterates up to 10% 2026 revenue growth while lowering cash cost guidance to ~$4B | 7 | Seeking Alpha | ||
| 18:10 | 3 Reasons Why Growth Investors Shouldn't Overlook Clean Harbors (CLH) | 2 | Zacks | ||
| 18:02 | OSR Health, Inc.: OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment | 196 | ACCESS Newswire | BELLEVUE, WA / ACCESS Newswire / July 31, 2026 / OSR Health, Inc. (NASDAQ:OSRH) ("OSR Health" or the "Company") today announced that the Nasdaq Stock Market ("Nasdaq") stated in a verbal communication... ► Artikel lesen | |
| 18:00 | PureTech Health PLC - PDMR Notification RSU Vesting | - | RNS | ||
| 17:46 | Sanofi to 'rebuild trust' with Regeneron; Apnimed adds to string of 'upsized' biotech IPOs | 4 | BioPharma Dive | ||
| 17:41 | STRYKER CORP - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 17:40 | XFRA 7R8: WIEDERAUFNAHME/RESUMPTION | 133 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 17:36 | Replimune rebounds as positive AdCom vote prompts Cantor upgrade | 3 | Seeking Alpha | ||
| 17:30 | TD Cowen raises Guardant Health stock price target on strong volume growth | 1 | Investing.com | ||
| 17:30 | Moderna Burns Cash, Suffers Fresh Vaccine Setback | 5 | Benzinga.com | ||
| 17:26 | TENAX THERAPEUTICS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 17:22 | TD Cowen erhöht Kursziel für Guardant Health Aktie nach starkem Volumenwachstum | 1 | Investing.com Deutsch | ||
| 17:12 | Weekly Buzz: Cipla, Viatris Win FDA Nod; Boston Scientific Cuts Jobs; argenx Snaps Up Forte Biosciences; Johnson & Johnson, GSK Strike Deals | 423 | AFX News | NEW BRUNSWICK (dpa-AFX) - The healthcare sector delivered another eventful week, marked by major regulatory approvals, strategic partnerships, acquisitions, restructuring initiatives and significant... ► Artikel lesen |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| MODERNA | 15 | 16 | -1,57 % | Ihre wichtigsten Termine: Spannende Zahlen von: Sony, Moderna, AbbVie, Eaton, ExxonMobil, Linde und Puma! | © Foto: picture alliance / CFOTO | CFOTOGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | ||
| STRYKER | 12 | 19 | -6,36 % | Stryker Corp. Bottom Line Rises In Q2 | WASHINGTON (dpa-AFX) - Stryker Corp. (SYK) revealed a profit for its second quarter that Increases, from the same period last yearThe company's bottom line came in at $1.276 billion, or $3.30... ► Artikel lesen | ||
| KARYOPHARM | 12 | 2 | -71,80 % | Karyopharm Therapeutics Inc.: Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer | - The Trial Did Not Meet the Primary Endpoint of Progression-Free Survival (PFS) -
- A Trend Favoring the Selinexor Arm was Observed with a 5.3 Month Improvement... ► Artikel lesen | ||
| NEUROCRINE BIOSCIENCES | 11 | 17 | -10,55 % | Neurocrine Biosciences Inc Q2 Profit Climbs | WASHINGTON (dpa-AFX) - Neurocrine Biosciences Inc (NBIX) released earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $144.4 million, or $1.39 per... ► Artikel lesen | ||
| REPLIMUNE | 10 | 1 | +95,64 % | XFRA 7R8: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILREPLIMUNE GR. INC... ► Artikel lesen | ||
| GUARDANT HEALTH | 8 | 2 | +5,88 % | TD Cowen raises Guardant Health stock price target on strong volume growth | |||
| ILLUMINA | 8 | - | -2,01 % | Illumina Inc. Profit Retreats In Q2 | SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) revealed earnings for second quarter that Drops, from the same period last yearThe company's earnings came in at $207 million, or $1.35 per share.... ► Artikel lesen | ||
| VERACYTE | 6 | - | -26,88 % | Freedom Capital erhöht Kursziel für Veracyte nach starken Quartalszahlen | |||
| AMGEN | 5 | 27 | -1,00 % | Kleinzelliges Lungenkarzinom (SCLC): Hoch aggressiv und schwer behandelbar / Biotechnologieunternehmen Amgen engagiert sich in der Erforschung neuer Therapieansätze | München (ots) - Das kleinzellige Lungenkarzinom (Small Cell Lung Cancer, SCLC) ist eine der aggressivsten Formen von Lungenkrebs. Die Erkrankung schreitet besonders schnell voran, streut früh in andere... ► Artikel lesen | ||
| MOLECULIN BIOTECH | 5 | 3 | -63,57 % | Moleculin Biotech, Inc.: Moleculin Announces Pricing of $9.3 Million Public Offering | HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), today announced the pricing of a best-efforts public offering of an aggregate of... ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| NOVOGENIA AG | 6,200 | 24,75 | +299 % | 1 | - | - | |||
| NANOREPRO AG | 1,980 | 4,50 | +127 % | 2 | - | - | |||
| EVOTEC SE | 3,410 | 6,03 | +77 % | 3 | 3 | - | |||
| BIONTECH SE ADR | 79,05 | 117,79 | +49 % | 3 | - | - | |||
| SARTORIUS STEDIM BIOTECH SA | 166,40 | 230 | +38 % | 5 | 1 | - | |||
| ARGENX SE | 742,20 | 917,75 | +24 % | 20 | 1 | - | |||
| QIAGEN NV | 35,720 | 40 | +12 % | 5 | 2 | - | |||
| MODERNA INC | 49,420 | 38,28 | -23 % | - | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.